The DOI matches its Crossref record; 102 of the 102 references it cites were found in a registry or an index.
Recent advances in dendrimer-based nanovectors for tumor-targeted drug and gene delivery
Open accessAbstract
Advances in the application of nanotechnology in medicine have given rise to multifunctional smart nanocarriers that can be engineered with tunable physicochemical characteristics to deliver one or more therapeutic agent(s) safely and selectively to cancer cells, including intracellular organelle-specific targeting. Dendrimers having properties resembling biomolecules, with well-defined 3D nanopolymeric architectures, are emerging as a highly attractive class of drug and gene delivery vector. The presence of numerous peripheral functional groups on hyperbranched dendrimers affords efficient conjugation of targeting ligands and biomarkers that can recognize and bind to receptors overexpressed on cancer cells for tumor-cell-specific delivery. The present review compiles the recent advances in dendrimer-mediated drug and gene delivery to tumors by passive and active targeting principles with illustrative examples.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Hallmarks of Cancer: The Next Generation
Hanahan, D., & Weinberg, R. A. (2011) · Cell · doi:10.1016/j.cell.2011.02.013 · Cited by 66,590
Cancer incidence and mortality worldwide: Sources, methods and major patterns in GLOBOCAN 2012
Ferlay, J., Soerjomataram, I., Dikshit, R., Eser, S., Mathers, C., Rebelo, M., Parkin, D. M., Forman, D., & Bray, F. (2015) · International Journal of Cancer · doi:10.1002/ijc.29210 · Cited by 28,766
Nanocarriers as an emerging platform for cancer therapy
Peer, D., Karp, J. M., Hong, S., Farokhzad, O. C., Margalit, R., & Langer, R. (2007) · Nature Nanotechnology · doi:10.1038/nnano.2007.387 · Cited by 8,710
Matsumura, Y., & Maeda, H. (1986) · PubMed · Cited by 6,781
Tumor vascular permeability and the EPR effect in macromolecular therapeutics: a review
Maeda, H., Wu, J., Sawa, T., Matsumura, Y., & Hori, K. (2000) · Journal of Controlled Release · doi:10.1016/s0168-3659(99)00248-5 · Cited by 6,565 · cited 1×
“In addition, tumor cells secrete excessive levels of vascular permeability mediators that facilitate dilation of blood vessels [10,45,46,49].”
BackgroundMultidrug resistance in cancer: role of ATP–dependent transporters
Gottesman, M. M., Fojo, T., & Bates, S. E. (2002) · Nature Reviews Cancer · doi:10.1038/nrc706 · Cited by 5,536
A New Class of Polymers: Starburst-Dendritic Macromolecules
Tomalia, D. A., Baker, H., Dewald, J., Hall, M., Kallos, G., Martin, S., Roeck, J., Ryder, J., & Smith, P. (1985) · Polymer Journal · doi:10.1295/polymj.17.117 · Cited by 3,904
Knocking down barriers: advances in siRNA delivery
Whitehead, K. A., Langer, R., & Anderson, D. G. (2009) · Nature Reviews Drug Discovery · doi:10.1038/nrd2742 · Cited by 3,115
Nanoparticles in cancer therapy and diagnosis
Brigger, I., Dubernet, C., & Couvreur, P. (2002) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(02)00044-3 · Cited by 3,039
Maeda, H. (2001) · Advances in Enzyme Regulation · doi:10.1016/s0065-2571(00)00013-3 · Cited by 2,495
Exploiting the enhanced permeability and retention effect for tumor targeting
Iyer, A. K., Khaled, G., Fang, J., & Maeda, H. (2006) · Drug Discovery Today · doi:10.1016/j.drudis.2006.07.005 · Cited by 1,846 · cited 3×
“In addition, tumor cells secrete excessive levels of vascular permeability mediators that facilitate dilation of blood vessels [10,45,46,49].”
BackgroundSelf-citationVascular permeability in a human tumor xenograft: molecular size dependence and cutoff size.
Yuan, F., Dellian, M., Fukumura, D., Leunig, M., Berk, D. A., Torchilin, V. P., & Jain, R. K. (1995) · PubMed · Cited by 1,711
Dendrimers and dendritic polymers in drug delivery
Gillies, E. R., & Fréchet, J. M. J. (2005) · Drug Discovery Today · doi:10.1016/s1359-6446(04)03276-3 · Cited by 1,367
Nanotech approaches to drug delivery and imaging
Sahoo, S. K., & Labhasetwar, V. (2003) · Drug Discovery Today · doi:10.1016/s1359-6446(03)02903-9 · Cited by 1,203
Dendrimer biocompatibility and toxicity
DUNCAN, R., & IZZO, L. (2005) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2005.09.019 · Cited by 1,158
Dendrimer as nanocarrier for drug delivery
Kesharwani, P., Jain, K., & Jain, N. K. (2014) · Progress in Polymer Science · doi:10.1016/j.progpolymsci.2013.07.005 · Cited by 1,146
Self-citationTomalia, D. A. (2005) · Progress in Polymer Science · doi:10.1016/j.progpolymsci.2005.01.007 · Cited by 1,115
Lipid-Based Nanoparticles as Pharmaceutical Drug Carriers: From Concepts to Clinic
Puri, A., Loomis, K., Smith, B., Lee, J.-H., Yavlovich, A., Heldman, E., & Blumenthal, R. (2009) · Critical Reviews in Therapeutic Drug Carrier Systems · doi:10.1615/critrevtherdrugcarriersyst.v26.i6.10 · Cited by 1,069
Barriers to Drug Delivery in Solid Tumors
Jain, R. K. (1994) · Scientific American · doi:10.1038/scientificamerican0794-58 · Cited by 1,069
Maeda, H., Sawa, T., & Konno, T. (2001) · Journal of Controlled Release · doi:10.1016/s0168-3659(01)00309-1 · Cited by 925
Tumor Vascular Permeability, Accumulation, and Penetration of Macromolecular Drug Carriers
Dreher, M. R., Liu, W., Michelich, C. R., Dewhirst, M. W., Yuan, F., & Chilkoti, A. (2006) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/djj070 · Cited by 920
RNAi therapeutics: Principles, prospects and challenges
Aagaard, L., & Rossi, J. J. (2007) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2007.03.005 · Cited by 895
Quintana, A., Raczka, E., Piehler, L., Lee, I., Myc, A., Majoros, I., Patri, A. K., Thomas, T., Mulé, J., & Baker, J. R. (2002) · Pharmaceutical Research · doi:10.1023/a:1020398624602 · Cited by 663
Liu, Y., Miyoshi, H., & Nakamura, M. (2007) · International Journal of Cancer · doi:10.1002/ijc.22709 · Cited by 620
PATRI, A., KUKOWSKALATALLO, J., & BAKERJR, J. (2005) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2005.09.014 · Cited by 597
A PEGylated dendritic nanoparticulate carrier of fluorouracil
Bhadra, D., Bhadra, S., Jain, S., & Jain, N. K. (2003) · International Journal of Pharmaceutics · doi:10.1016/s0378-5173(03)00132-7 · Cited by 544
Dendrimers: Emerging polymers for drug-delivery systems
Nanjwade, B. K., Bechra, H. M., Derkar, G. K., Manvi, F. V., & Nanjwade, V. K. (2009) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2009.07.008 · Cited by 542
Emerging concepts in dendrimer‐based nanomedicine: from design principles to clinical applications
Kannan, R. M., Nance, E., Kannan, S., & Tomalia, D. A. (2014) · Journal of Internal Medicine · doi:10.1111/joim.12280 · Cited by 542
Dendrimers as multi-purpose nanodevices for oncology drug delivery and diagnostic imaging
Tomalia, D. A., Reyna, L. A., & Svenson, S. (2007) · Biochemical Society Transactions · doi:10.1042/bst0350061 · Cited by 496
Dendrimers in Oncology: An Expanding Horizon
Tekade, R. K., Kumar, P. V., & Jain, N. K. (2009) · Chemical Reviews · doi:10.1021/cr068212n · Cited by 466
Passive targeting of nanoparticles to cancer: A comprehensive review of the literature
BAZAK, R., HOURI, M., ACHY, S. E., HUSSEIN, W., & REFAAT, T. (2014) · Molecular and Clinical Oncology · doi:10.3892/mco.2014.356 · Cited by 435
Designing dendrimers for drug delivery
Liu, M., & Fréchet, J. M. J. (1999) · Pharmaceutical Science & Technology Today · doi:10.1016/s1461-5347(99)00203-5 · Cited by 434
Polymeric nanoparticles for cancer therapy
Parveen, S., & Sahoo, S. K. (2008) · Journal of Drug Targeting · doi:10.1080/10611860701794353 · Cited by 427
Pharmaceutical nanotechnology for oral delivery of anticancer drugs
Mei, L., Zhang, Z., Zhao, L., Huang, L., Yang, X.-L., Tang, J., & Feng, S.-S. (2013) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2012.11.005 · Cited by 373
Prospects of RNA interference therapy for cancer
Pai, S. I., Lin, Y.-Y., Macaes, B., Meneshian, A., Hung, C.-F., & Wu, T.-C. (2006) · Gene Therapy · doi:10.1038/sj.gt.3302694 · Cited by 352
Role of integrated cancer nanomedicine in overcoming drug resistance
Iyer, A. K., Singh, A., Ganta, S., & Amiji, M. M. (2013) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2013.07.012 · Cited by 343
Self-citationTaratula, O., Garbuzenko, O. B., Kirkpatrick, P., Pandya, I., Savla, R., Pozharov, V. P., He, H., & Minko, T. (2009) · Journal of Controlled Release · doi:10.1016/j.jconrel.2009.06.019 · Cited by 328
PEGylated Poly(amidoamine) dendrimer-based dual-targeting carrier for treating brain tumors
He, H., Li, Y., Jia, X.-R., Du, J., Ying, X., Lu, W.-L., Lou, J.-N., & Wei, Y. (2011) · Biomaterials · doi:10.1016/j.biomaterials.2010.09.002 · Cited by 303
Fast and Convenient Divergent Synthesis of Aliphatic Ester Dendrimers by Anhydride Coupling
Ihre, H., Padilla De Jesús, O. L., & Fréchet, J. M. J. (2001) · Journal of the American Chemical Society · doi:10.1021/ja010524e · Cited by 296
Targeting cancer cells with biotin–dendrimer conjugates
Yang, W., Cheng, Y., Xu, T., Wang, X., & Wen, L.-P. (2009) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2008.04.021 · Cited by 290
Greish, K., Fang, J., Inutsuka, T., Nagamitsu, A., & Maeda, H. (2003) · Clinical Pharmacokinetics · doi:10.2165/00003088-200342130-00002 · Cited by 278
In Vitro Gene Transfection Using Dendritic Poly(l-lysine)
Ohsaki, M., Okuda, T., Wada, A., Hirayama, T., Niidome, T., & Aoyagi, H. (2002) · Bioconjugate Chemistry · doi:10.1021/bc015525a · Cited by 264
She, W., Li, N., Luo, K., Guo, C., Wang, G., Geng, Y., & Gu, Z. (2013) · Biomaterials · doi:10.1016/j.biomaterials.2012.12.017 · Cited by 258
Therapeutic Nanoparticles in Clinics and Under Clinical Evaluation
Schütz, C. A., Juillerat-Jeanneret, L., Mueller, H., Lynch, I., & Riediker, M. (2013) · Nanomedicine · doi:10.2217/nnm.13.8 · Cited by 242
Abolmaali, S. S., Tamaddon, A. M., & Dinarvand, R. (2013) · Cancer Chemotherapy and Pharmacology · doi:10.1007/s00280-012-2062-0 · Cited by 240
Arima, H., Kihara, F., Hirayama, F., & Uekama, K. (2001) · Bioconjugate Chemistry · doi:10.1021/bc000111n · Cited by 222
Surface-Modified and Internally Cationic Polyamidoamine Dendrimers for Efficient siRNA Delivery
Patil, M. L., Zhang, M., Betigeri, S., Taratula, O., He, H., & Minko, T. (2008) · Bioconjugate Chemistry · doi:10.1021/bc8000722 · Cited by 213
Li, X., Takashima, M., Yuba, E., Harada, A., & Kono, K. (2014) · Biomaterials · doi:10.1016/j.biomaterials.2014.04.043 · Cited by 212
Patil, M. L., Zhang, M., & Minko, T. (2011) · ACS Nano · doi:10.1021/nn102711d · Cited by 210
Kaminskas, L. M., Boyd, B. J., & Porter, C. J. (2011) · Nanomedicine · doi:10.2217/nnm.11.67 · Cited by 204
Engineered Nanoparticles in Cancer Therapy
Praetorius, N., & Mandal, T. (2007) · Recent Patents on Drug Delivery & Formulation · doi:10.2174/187221107779814104 · Cited by 196
Kaminskas, L. M., McLeod, V. M., Ryan, G. M., Kelly, B. D., Haynes, J. M., Williamson, M., Thienthong, N., Owen, D. J., & Porter, C. J. H. (2014) · Journal of Controlled Release · doi:10.1016/j.jconrel.2014.03.012 · Cited by 190
Cancer targeting potential of some ligand-anchored poly(propylene imine) dendrimers: a comparison
Kesharwani, P., Tekade, R. K., Gajbhiye, V., Jain, K., & Jain, N. K. (2011) · Nanomedicine: Nanotechnology, Biology and Medicine · doi:10.1016/j.nano.2010.10.010 · Cited by 184
Self-citationExploring dendrimer towards dual drug delivery: pH responsive simultaneous drug-release kinetics
Tekade, R. K., Dutta, T., Gajbhiye, V., & Jain, N. K. (2009) · Journal of Microencapsulation · doi:10.1080/02652040802312572 · Cited by 181
Shah, V., Taratula, O., Garbuzenko, O. B., Taratula, O. R., Rodriguez-Rodriguez, L., & Minko, T. (2013) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-13-1536 · Cited by 173
Fluorinated poly(propylenimine) dendrimers as gene vectors
Liu, H., Wang, Y., Wang, M., Xiao, J., & Cheng, Y. (2014) · Biomaterials · doi:10.1016/j.biomaterials.2014.03.040 · Cited by 157
Taratula, O., Garbuzenko, O. B., Savla, R., Wang, Y. A., He, H., & Minko, T. (2010) · Current Drug Delivery · doi:10.2174/156720111793663642 · Cited by 154
Al‐Jamal, K. T., Al-Jamal, W. T., Wang, J. T.-W., Rubio, N., Buddle, J. C., Gathercole, D., Zloh, M., & Kostarelos, K. (2013) · ACS Nano · doi:10.1021/nn305860k · Cited by 154
Generation dependent cancer targeting potential of poly(propyleneimine) dendrimer
Kesharwani, P., Tekade, R. K., & Jain, N. K. (2014) · Biomaterials · doi:10.1016/j.biomaterials.2014.03.064 · Cited by 153
Self-citationFu, F., Wu, Y., Zhu, J., Wen, S., Shen, M., & Shi, X. (2014) · ACS Applied Materials & Interfaces · doi:10.1021/am504849x · Cited by 151
Dufès, C., Keith, W. N., Bilsland, A. E., Proutski, I., Uchegbu, I. F., & Schätzlein, A. G. (2005) · Cancer Research · doi:10.1158/0008-5472.can-04-4402 · Cited by 146
Crampton, H. L., & Simanek, E. E. (2007) · Polymer International · doi:10.1002/pi.2230 · Cited by 146
Dendrimer Nanoscaffolds for Potential Theranostics of Prostate Cancer with a Focus on Radiochemistry
Lo, S., Kumar, A., Hsieh, J., & Sun, X. (2013) · Molecular Pharmaceutics · doi:10.1021/mp3005325 · Cited by 140
Dande, P., Prakash, T. P., Sioufi, N. B., Gaus, H. J., Jarres, R., Berdeja, A., Swayze, E. E., Griffey, R. H., & Bhat, B. (2006) · Journal of Medicinal Chemistry · doi:10.1021/jm050822c · Cited by 138
Zheng, W., Cao, C., Liu, Y., Yu, Q., Zheng, C., Sun, D., Ren, X., & Liu, J. (2014) · Acta Biomaterialia · doi:10.1016/j.actbio.2014.08.035 · Cited by 134
Ruß, V., Gunther, M. J., Halama, A., Ogris, M., & Wagner, E. (2008) · Journal of Controlled Release · doi:10.1016/j.jconrel.2008.09.003 · Cited by 127
Novel RNA oligonucleotide improves liver function and inhibits liver carcinogenesis in vivo
Reebye, V., Sætrom, P., Mintz, P. J., Huang, K., Swiderski, P. M., Peng, L., Liu, C., Liu, X., Lindkær-Jensen, S., Zacharoulis, D., et al. (2013) · Hepatology · doi:10.1002/hep.26669 · Cited by 126
Active targeting of cancer cells using folic acid-conjugated platinum nanoparticles
Teow, Y., & Valiyaveettil, S. (2010) · Nanoscale · doi:10.1039/c0nr00204f · Cited by 125
The treatment of Glioblastoma Xenografts by surfactant conjugated dendritic nanoconjugates
Gajbhiye, V., & Jain, N. K. (2011) · Biomaterials · doi:10.1016/j.biomaterials.2011.04.057 · Cited by 120
Dextran conjugated dendritic nanoconstructs as potential vectors for anti-cancer agent
Agarwal, A., Gupta, U. D., Asthana, A., & Jain, N. K. (2009) · Biomaterials · doi:10.1016/j.biomaterials.2009.03.016 · Cited by 119
Combinatorial-Designed Multifunctional Polymeric Nanosystems for Tumor-Targeted Therapeutic Delivery
Abeylath, S. C., Ganta, S., Iyer, A. K., & Amiji, M. M. (2011) · Accounts of Chemical Research · doi:10.1021/ar2000106 · Cited by 119
Self-citationIntravascular and Endobronchial DNA Delivery to Murine Lung Tissue Using a Novel, Nonviral Vector
Kukowska‐Latallo, J. F., Chen, C., Raczka, E., Qunintana, A., Rymaszewski, M., & Baker, J. R. (2000) · Human Gene Therapy · doi:10.1089/10430340050057468 · Cited by 116
Man, N., Yiyun, C., Xu, T., Ding, Y., Xiaomin, W., Li, Z., Zhichao, C., Huang, G., Shi, Y., & Wen, L. (2006) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2006.01.001 · Cited by 113
Kesharwani, P., Tekade, R. K., & Jain, N. K. (2014) · Nanomedicine · doi:10.2217/nnm.13.210 · Cited by 108
Self-citationLigand anchored dendrimers based nanoconstructs for effective targeting to cancer cells
Gupta, U. D., Dwivedi, S. K. D., Bid, H. K., Konwar, R., & Jain, N. K. (2010) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2010.04.002 · Cited by 107
Carbon nanotube exploration in cancer cell lines
Kesharwani, P., Ghanghoria, R., & Jain, N. K. (2012) · Drug Discovery Today · doi:10.1016/j.drudis.2012.05.003 · Cited by 100
Self-citationIslam, T., & Josephson, L. (2009) · Cancer Biomarkers · doi:10.3233/cbm-2009-0615 · Cited by 96
Hui, H., Xiao-dong, F., & Zhong-lin, C. (2005) · Polymer · doi:10.1016/j.polymer.2005.07.034 · Cited by 91
Enzyme-activated nanoconjugates for tunable release of doxorubicin in hepatic cancer cells
Medina, S. H., Chevliakov, M. V., Tiruchinapally, G., Durmaz, Y. Y., Kuruvilla, S. P., & ElSayed, M. E. H. (2013) · Biomaterials · doi:10.1016/j.biomaterials.2013.02.070 · Cited by 90
Vincent, L., Varet, J., Pille, J., Bompais, H., Opolon, P., Maksimenko, A., Malvy, C., Mirshahi, M., Lu, H., Vannier, J., et al. (2003) · International Journal of Cancer · doi:10.1002/ijc.11105 · Cited by 88
Thakur, S., Tekade, R. K., Kesharwani, P., & Jain, N. K. (2013) · Journal of Nanoparticle Research · doi:10.1007/s11051-013-1625-2 · Cited by 85
Self-citationDendrimer–TPGS mixed micelles for enhanced solubility and cellular toxicity of taxanes
Pooja, D., Kulhari, H., Singh, M. K., Mukherjee, S., Rachamalla, S. S., & Sistla, R. (2014) · Colloids and Surfaces B Biointerfaces · doi:10.1016/j.colsurfb.2014.06.059 · Cited by 84
Surface modified dendrimers: Synthesis and characterization for cancer targeted drug delivery
Sharma, A., Gautam, S. P., & Gupta, A. K. (2011) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2011.04.046 · Cited by 70
Wada, K., Arima, H., Tsutsumi, T., Hirayama, F., & Uekama, K. (2005) · Biological and Pharmaceutical Bulletin · doi:10.1248/bpb.28.500 · Cited by 69
Zhang, Y., Thomas, T. P., Lee, K.-H., Li, M., Zong, H., Desai, A. M., Kotlyar, A., Huang, B., Holl, M. M. B., & Baker, J. R. (2011) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2011.03.019 · Cited by 67
Dhakad, R., Tekade, R. K., & Jain, N. K. (2013) · Current Drug Delivery · doi:10.2174/1567201811310040012 · Cited by 61
Dendrimer-enabled DNA delivery and transformation of Chlamydia pneumoniae
Gérard, H. C., Mishra, M. K., Mao, G., Wang, S., Hali, M., Whittum‐Hudson, J. A., Kannan, R. M., & Hudson, A. P. (2013) · Nanomedicine Nanotechnology Biology and Medicine · doi:10.1016/j.nano.2013.04.004 · Cited by 59
Yalçın, S., Erkan, M., Ünsoy, G., Parsian, M., Kleeff, J. H., & Gündüz, U. (2014) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2014.07.003 · Cited by 58
Dendrimer-triglycine-EGF nanoparticles for tumor imaging and targeted nucleic acid and drug delivery
Yuan, Q., Lee, E., Yeudall, W. A., & Yang, H. (2010) · Oral Oncology · doi:10.1016/j.oraloncology.2010.07.001 · Cited by 58
Jia, L., Xu, J., Wang, H., & Ji, J. (2010) · Colloids and Surfaces B Biointerfaces · doi:10.1016/j.colsurfb.2010.12.012 · Cited by 57
Wang, F., Cai, X., Su, Y., Hu, J., Wu, Q., Zhang, H., Xiao, J., & Cheng, Y. (2012) · Acta Biomaterialia · doi:10.1016/j.actbio.2012.07.031 · Cited by 57
New cyclodextrin derivative containing poly(L-lysine) dendrons for gene and drug co-delivery
Ma, D., Zhang, H.-B., Chen, Y.-Y., Lin, J., & Zhang, L. (2013) · Journal of Colloid and Interface Science · doi:10.1016/j.jcis.2013.05.017 · Cited by 56
Nanodelivery Systems for Nucleic Acid Therapeutics in Drug Resistant Tumors
Iyer, A. K., Duan, Z., & Amiji, M. M. (2014) · Molecular Pharmaceutics · doi:10.1021/mp500024p · Cited by 55
Self-citationLiu, X., Liu, C., Chen, C., Bentobji, M., Azario-Cheillan, F., Piana, J. T., Qu, F., Rocchi, P., & Peng, L. (2014) · Nanomedicine Nanotechnology Biology and Medicine · doi:10.1016/j.nano.2014.05.008 · Cited by 53
Nanomaterials in Stroke Treatment
Shcharbina, N., Shcharbin, D., & Bryszewska, M. J. (2013) · Stroke · doi:10.1161/strokeaha.113.001298 · Cited by 46
Anthracycline antibiotics induce acute renal tubular toxicity in children with cancer
Bárdi, E., Bobok, I., Oláh, A. V., et al. (2007) · Pathology & Oncology Research · doi:10.1007/bf02893506 · Cited by 43
Sideratou, Z., Kontoyianni, C., Drossopoulou, G. I., & Paleos, C. M. (2010) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2010.09.058 · Cited by 40
Birdhariya, B., Kesharwani, P., & Jain, N. K. (2014) · Drug Development and Industrial Pharmacy · doi:10.3109/03639045.2014.954584 · Cited by 39
Self-citationWang, K., Zhang, X., Zhang, L., Qian, L., Liu, C., Zheng, J., & Jiang, Y. (2014) · Drug Delivery · doi:10.3109/10717544.2014.895457 · Cited by 37
Spectrophotometric estimation of paclitaxel
Kesarwani, P., Tekade, R. K., & Jain, N. K. (2011) · International Journal of Phytomedicine · Cited by 34
Gu, Z.-J., Wang, M., Fang, Q., Zheng, H., Wu, F., Lin, D., Xu, Y. M., & Jin, Y. (2014) · Drug Development and Industrial Pharmacy · doi:10.3109/03639045.2014.908899 · Cited by 29
Hydrophobic cavity formed by oligopeptide for doxorubicin delivery based on dendritic poly(L-lysine)
Niidome, T., Yamauchi, H., Takahashi, K., Naoyama, K., Watanabe, K., Mori, T., & Katayama, Y. (2014) · Journal of Biomaterials Science Polymer Edition · doi:10.1080/09205063.2014.938979 · Cited by 23
Cited by
Kalyane, D., Raval, N., Maheshwari, R., Tambe, V., Kalia, K., & Tekade, R. K. (2019) · Materials Science and Engineering: C · doi:10.1016/j.msec.2019.01.066 · Cited by 849
Martins, P., Jesus, J., Santos, S., Raposo, L., Roma-Rodrigues, C., Baptista, P., & Fernandes, A. (2015) · Molecules · doi:10.3390/molecules200916852 · Cited by 716
Dendrimers as Nanocarriers for Nucleic Acid and Drug Delivery in Cancer Therapy
Palmerston Mendes, L., Pan, J., & Torchilin, V. (2017) · Molecules · doi:10.3390/molecules22091401 · Cited by 701
Preparation and application of pH-responsive drug delivery systems
Ding, H., Tan, P., Fu, S., Tian, X., Zhang, H., Ma, X., Gu, Z., & Luo, K. (2022) · Journal of Controlled Release · doi:10.1016/j.jconrel.2022.05.056 · Cited by 645
Injectable hydrogel-based drug delivery systems for local cancer therapy
Norouzi, M., Nazari, B., & Miller, D. W. (2016) · Drug Discovery Today · doi:10.1016/j.drudis.2016.07.006 · Cited by 558
Metadata
- Authors
- Kesharwani, P., & Iyer, A. K.
- Venue
- Drug Discovery Today
- Publisher
- Elsevier BV
- Published
- 2015-05
- Volume
- 20
- Issue
- 5
- Pages
- 536-547
- ISSN
- 1359-6446 (ISSN-L)
- OpenAlex
- W2050881037
- Cited by
- 380
- References
- 102
- FWCI
- 19.10
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.